Screener
Zevra Therapeutics, Inc. ZVRA Business Segments — Impairment of intangible assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative directly identified to programs | 3,132 | 6,439 | 9,564 | 14,000 |
| Selling, general and administrative not directly identified to programs | 13,427 | 14,343 | 27,778 | 26,327 |
| Other segment items: | ||||
| Impairment of intangible assets | — | 58,710 | — | 58,710 |
| Income tax expense | 4,042 | 2,199 | 10,957 | 3,381 |
| Interest income | (1,477) | (2,257) | (3,661) | (2,975) |
| Depreciation and amortization expense | 316 | 1,651 | 732 | 3,300 |
| Interest expense | — | 2,009 | 1,711 | 3,978 |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s business segments — impairment of intangible assets?
- Zevra Therapeutics, Inc. (ZVRA) reported business segments — impairment of intangible assets of $0 in Q2 2026.
- How has Zevra Therapeutics, Inc.'s business segments — impairment of intangible assets changed year-over-year?
- Zevra Therapeutics, Inc.'s business segments — impairment of intangible assets decreased by 100.0% year-over-year, from $58.71M to $0.
- What does business segments — impairment of intangible assets mean?
- Reflects the write-down of the carrying value of intangible assets when their fair value falls below their book value. This metric indicates potential challenges in the long-term value realization of acquired intellectual property or other intangible assets.
Ask your AI about Zevra Therapeutics, Inc.'s business segments — impairment of intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude